DUN'S 100 2016/17 - High-Tech & Technology Sector

68 / 74

Law Firms
High-Tech & Technology - DUN’S 100 | 2016/17 68
Law Firms - High-Tech
Horn & Co. Law Offices
Horn & Co. is the leading Israeli boutique
law firm in the field of hi-tech and life sci-
ences, and is unique in its exclusive prac-
tice and expertise in this field. The firm’s founder,
Yuval Horn, was recognized by the International
Who’s Who of Life Sciences Lawyers as one of the
five leading individuals in the world in life sciences
transactions in 2013, and again in 2015.
Horn &Co.’s expertise includes the representation
of clients in all aspects of their operations, includ-
ing especially their technology and intellectual
property transactions, their corporate and funding
matters and their commercial contracting.
Horn &Co. was founded inSeptember 2009 and is
known for its tailored, innovative structures, solu-
tions and advice in complex transactions and situ-
ations. Since 1993, both Yuval and his colleagues
have represented numerous founders, companies
and investors in their transactions in the life science
and technology sectors. Recent examples include
the representation of Ccam Biotherapeutics Ltd.
in its sale to Merck & Co., Inc. in the largest cash
based transaction in 2015 in the Israeli life sci-
ences field; the representation ofTaboola.comLtd.
in the largest private financing round of an Israeli
company (of over $130million); and the formation
of Pontifax4 L.P., the fourth fund of PontifaxVenture
Capital group, Israel’smost prominent life sciences
designated investment fund.
Horn & Co. is the Israeli member of Biolegis (www.
), a network of leading European law
firmswith specific expertise in the representation of
biotechnology and medical device companies.
The firm’s partners and associates have been rec-
ognized by the leading international publications
and peers as experts in corporate law, intellectual
property and technology transactions and are typi-
cally asked to lecture and write about these areas.
Yuval has been recognized as an expert in life sci-
ences by the International Who’s Who Legal: Life
Sciences during the years 2008-2016. Since 2008
he has been a member and legal advisor of the
Institutional ReviewBoard (Helsinki Committee) of
the ChaimSheba Medical Center at Tel-Hashomer,
Israel’s largest medical facility. Yuval currently
serves as the Co-Chair of the International Bar As-
sociation (IBA) Technology Law Committee, and is
a member of the Executive Committee of the IBA
Annual World Life Sciences Conference. In 2016,
Yuval co-chaired the IBA M&A in the Technology
Sector conference in Tel Aviv.
Corporate
Horn & Co. has vast experience in the representa-
tion of biotechnology, medical device, software,
telecommunications and cleantech companies. Its
corporate clients include companies of all sizes,
from Israeli based incubator companies tomultina-
tional companies conducting business in Israel.
Intellectual Property Transactions
The firm was recently selected by IAM Magazine
as one of the top 3 highly recommended Israeli
firms in the field of licensing stating that “Horn &
Co is a great office for licensing… the group shines
at the commercialization of innovative technolo-
gies… Hotly tipped for his business acumen, Yuval
Horn is a consummate dealmaker”. With a thor-
ough understanding of the specific complexities
and needs of technology-based, long-haul devel-
opment companies, the firm represents clients in
all aspects of strategic transactions. Recent trans-
actions include dozens of agreements with tech-
nology transfer companies of the world’s leading
academic institutions, and the services and license
agreement between Zebra Medical Vision Ltd. and
Dell Services.
Mergers & Acquisitions
The firm has a substantial track-record in repre-
sentation of purchasers and targets in private and
publicM&A transactions, and iswidely experienced
in private and publicmergers includes the involve-
ment and advice in reverse mergers, mergers into
publicly traded shells, asset purchases and share
acquisitions. Some recent examples are the repre-
sentation of cCamBiotherapeutics Ltd. in its sale to
Merck & Co. Inc., and the representation of Israeli
shareholders inmergers and in significant second-
ary sales to strategic acquirers.
Regulation
Horn & Co. regularly advises international and Is-
raeli companies with respect to their relationships
with the Israel Innovation Authority, and assists in
structuring both local and cross-borders technol-
ogy transactions so to adequately conform to ap-
plicable regulations and lawful requirements. The
firm has advised several multinational companies
with respect to the incorporation and setting up of
businesses in Israel, as well as their relationships
with the Israel Innovation Authority and theMinistry
of Health. Horn&Co. is the Israeli member ofTRACE
and authored the Is-
raeli chapter on anti-corruption issues in “Getting
the Deal Through”.
Securities and Capital Markets
Horn & Co. regularly advises Israeli and interna-
tional clients on their full range of corporate finance
transactions.The firmhas special experience in reg-
istration and issuance of securities of technology
companies on USand Israeli securities exchanges,
including IPOs, follow-on offerings and PIPEs and is
ranked as such in international publications. Recent
transactions included acting as Israeli counsel to
ProtalixBioTherapeutics, Inc. (NYSE: PLX) in a $54.1
million private notes exchange agreement, and a
$22.5 million private placement of the company’s
Secured Convertible Notes, the representation of
Vascular Biogenics Ltd. in as series of follow-on of-
ferings on NASDAQwith an aggregate value of over
$40 million, and the representation of two Israeli
publicly traded companies in NASDAQ offerings.
Venture Capital
Horn & Co. advises companies, founders, govern-
ment funded incubators, private investors and ven-
ture capital funds with respect to their full range
of finance transactions, including seed rounds,
venture capital funding, venture lending, strategic
partner investments andmergers and acquisitions.
Our close acquaintance with both company and
investor needs and limitations further enables us
to provide a unique view and expertise to transac-
tions. We have been involved in the formation of
venture capital funds, and regularly advise such
funds with respect to their relationships with their
limited partners. We represent funds in their initial
and investments and continued involvement with
portfolio companies.
Esta b l i s h e d
2009
L i n e o f B u s i n ess
Hi-Tech, M&A, IP, Securities Law
pa rt n e r s
Keren Kanir
Roy Ribon
Ohad Mamann
Orly Sternfeld
Paz Abercohen
2 Weizmann St., Amot Investments Tower
24 floor, Tel Aviv 6423902
Tel: 972-3-637-8200
Fax:972-3-637-8201
Yuval Horn
Founding Partner